Review

Published on 17 May 2023

The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity

in Molecular and Cellular Oncology

Vincenzo Salemme
Giorgia Centonze
Lidia Avalle
Dora Natalini
Alessio Piccolantonio
Pietro Arina
Alessandro Morellato
Ugo Ala
Daniela Taverna
Emilia Turco

Frontiers in Oncology

doi 10.3389/fonc.2023.1170264

6,518 views
21 citations

Editorial

Published on 16 May 2023

Editorial: Case reports in molecular and cellular oncology: 2022

in Molecular and Cellular Oncology

Shuhua Zheng
Tarita O. Thomas

Frontiers in Oncology

doi 10.3389/fonc.2023.1209048

1,043 views

Original Research

Published on 12 May 2023

Comprehensive analysis and molecular map of Hippo signaling pathway in lower grade glioma: the perspective toward immune microenvironment and prognosis

in Molecular and Cellular Oncology

Yu-Duo Guo
Jie Sun
Chao Zhao
Le Han
Chun-Jiang Yu
Hong-Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1198414

1,979 views

Original Research

Published on 10 May 2023

Austrian tricentric real-life analysis of molecular profiles of metastatic biliary tract cancer patients

in Molecular and Cellular Oncology

Hossein Taghizadeh
Theresa Schmalfuss
Agnieszka Maj-Hes
Josef Singer
Gerald W. Prager

Frontiers in Oncology

doi 10.3389/fonc.2023.1143825

1,987 views
1 citation

Brief Research Report

Published on 10 May 2023

FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer–gene programs in basal-like breast cancer

in Molecular and Cellular Oncology

Kohei Kumegawa
Liying Yang
Kenichi Miyata
Reo Maruyama

Frontiers in Oncology

doi 10.3389/fonc.2023.1156111

1,761 views
5 citations

Mini Review

Published on 10 May 2023

Regulation of tumor angiogenesis by the crosstalk between innate immunity and endothelial cells

in Molecular and Cellular Oncology

Svenja Ebeling
Anita Kowalczyk
Diego Perez-Vazquez
Irene Mattiola

Frontiers in Oncology

doi 10.3389/fonc.2023.1171794

3,075 views
11 citations

Original Research

Published on 09 May 2023

Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated epithelial-to-mesenchymal transition

in Molecular and Cellular Oncology

Enrico Capobianco
Vanessa McGaughey
Gerbenn Seraphin
John Heckel
Sandra Rieger
Thomas S. Lisse

Frontiers in Oncology

doi 10.3389/fonc.2023.1188641

3,461 views
5 citations

Mini Review

Published on 08 May 2023

MAP4K4 and cancer: ready for the main stage?

in Molecular and Cellular Oncology

Jaime González-Montero
Carlos I. Rojas
Mauricio Burotto

Frontiers in Oncology

doi 10.3389/fonc.2023.1162835

3,106 views
4 citations

Case Report

Published on 08 May 2023

Case Report: Lung adenocarcinoma associated with germline ERCC2 frameshift mutation

in Molecular and Cellular Oncology

Lili Liu
Jia Cui
Siye Liu
Evenki Pan
Limin Sun

Frontiers in Oncology

doi 10.3389/fonc.2023.1177942

1,758 views
1 citation

Original Research

Published on 08 May 2023

A triple-drug combination induces apoptosis in cervical cancer-derived cell lines

in Molecular and Cellular Oncology

Izamary Delgado-Waldo
Carlos Contreras-Romero
Sandra Salazar-Aguilar
João Pessoa
Irma Mitre-Aguilar
Verónica García-Castillo
Carlos Pérez-Plasencia
Nadia Judith Jacobo-Herrera

Frontiers in Oncology

doi 10.3389/fonc.2023.1106667

2,663 views
3 citations

Review

Published on 05 May 2023

Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles

in Molecular and Cellular Oncology

Azar Gharoonpour
Dorsa Simiyari
Ali Yousefzadeh
Fatemeh Badragheh
Marveh Rahmati

Frontiers in Oncology

doi 10.3389/fonc.2023.1150492

2,778 views
5 citations

Original Research

Published on 03 May 2023

TYROBP-positive endothelial cell-derived TWEAK as a promoter of osteosarcoma progression: insights from single-cell omics

in Molecular and Cellular Oncology

Zhi-qiang Wei
Sheng Ding
Yan-cai Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1200203

2,094 views
7 citations

Correction

Published on 03 May 2023

Corrigendum: HSP70 and HSP90 in cancer: cytosolic, endoplasmic reticulum and mitochondrial chaperones of tumorigenesis

in Molecular and Cellular Oncology

Zarema Albakova
Yana Mangasarova
Akhmet Albakov
Liliya Gorenkova

Frontiers in Oncology

doi 10.3389/fonc.2023.1210051

1,134 views

Original Research

Published on 03 May 2023

The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway

in Molecular and Cellular Oncology

Peng Liu
Songbai Liu
Changhao Zhu
Yongning Li
Ying Li
Xiaobin Fei
Junyi Hou
Xing Wang
Yaozhen Pan

Frontiers in Oncology

doi 10.3389/fonc.2023.1169833

2,370 views
3 citations

Review

Published on 02 May 2023

Lipid metabolism in tumor immunology and immunotherapy

in Molecular and Cellular Oncology

Lisa K. Duong
Halil Ibrahim Corbali
Thomas S. Riad
Shonik Ganjoo
Selene Nanez
Tiffany Voss
Hampartsoum B. Barsoumian
James Welsh
Maria Angelica Cortez

Frontiers in Oncology

doi 10.3389/fonc.2023.1187279

2,731 views
4 citations

Review

Published on 02 May 2023

The key role of microRNA-766 in the cancer development

in Molecular and Cellular Oncology

Jitendra Gupta
Hussein Riyadh Abdul Kareem Al-Hetty
Murtadha Sh. Aswood
Abduladheem Turki Jalil
Maha Dhurgham Azeez
Zafar Aminov
Fahad Alsaikhan
Andrés Alexis Ramírez-Coronel
Pushpamala Ramaiah
Bagher Farhood

Frontiers in Oncology

doi 10.3389/fonc.2023.1173827

2,415 views
6 citations

Navigation group

Articles

The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity

Editorial: Case reports in molecular and cellular oncology: 2022

Comprehensive analysis and molecular map of Hippo signaling pathway in lower grade glioma: the perspective toward immune microenvironment and prognosis

Austrian tricentric real-life analysis of molecular profiles of metastatic biliary tract cancer patients

FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer–gene programs in basal-like breast cancer

Regulation of tumor angiogenesis by the crosstalk between innate immunity and endothelial cells

Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated epithelial-to-mesenchymal transition

MAP4K4 and cancer: ready for the main stage?

Case Report: Lung adenocarcinoma associated with germline ERCC2 frameshift mutation

A triple-drug combination induces apoptosis in cervical cancer-derived cell lines

Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles

TYROBP-positive endothelial cell-derived TWEAK as a promoter of osteosarcoma progression: insights from single-cell omics

Corrigendum: HSP70 and HSP90 in cancer: cytosolic, endoplasmic reticulum and mitochondrial chaperones of tumorigenesis

The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway

Lipid metabolism in tumor immunology and immunotherapy

The key role of microRNA-766 in the cancer development